In addition, CP alleviated colitis symptoms by blocking the activation of PI3K/AKT pathway in TNBS induced colitis in rats through the protein levels of AKT, BCL2, PI3K, and JNK2(Li F. et al., 2024). This evidence concerns the gene MAPK9 and colitis.